ORIENTGENE

ORIENTGENE.ORIENTGENE, established in 2005, is a high-tech enterprise specializing in in vitro diagnostic products. The company focuses on POCT (Point-of-Care Testing) reagents as its core business, with products widely applied in infectious disease, drug abuse, prenatal care, tumor, and cardiac biomarker detection. It holds particular competitive advantages in its two major product lines: infectious disease and drug abuse testing. While consolidating its market position in POCT, ORIENTGENE actively pursues a multi-technology platform development strategy. The company continuously invests in R&D across platforms including biological raw materials, molecular diagnostics, liquid biochips, and diagnostic instruments. Through an integrated innovation model, it drives long-term growth and is committed to providing comprehensive in vitro diagnostic solutions.